vs

Side-by-side financial comparison of Clear Channel Outdoor Holdings, Inc. (CCO) and SelectQuote, Inc. (SLQT). Click either name above to swap in a different company.

SelectQuote, Inc. is the larger business by last-quarter revenue ($537.1M vs $461.5M, roughly 1.2× Clear Channel Outdoor Holdings, Inc.). SelectQuote, Inc. runs the higher net margin — 12.9% vs 1.7%, a 11.2% gap on every dollar of revenue. On growth, SelectQuote, Inc. posted the faster year-over-year revenue change (11.6% vs 8.2%). Clear Channel Outdoor Holdings, Inc. produced more free cash flow last quarter ($30.3M vs $-1.0M). Over the past eight quarters, SelectQuote, Inc.'s revenue compounded faster (19.5% CAGR vs 18.8%).

Clear Channel Outdoor Holdings, Inc. is a multinational corporation focused on outdoor advertising. The company is based in San Antonio, Texas.

SelectQuote is a direct-to-consumer distribution platform for selling insurance policies and healthcare services. Their insurance business earns commissions by connecting consumers with insurance carriers that provide senior health, life, automobile, and home insurance. The healthcare services business mainly consists of SelectRx, an accredited pharmacy. The company went public on May 21, 2020.

CCO vs SLQT — Head-to-Head

Bigger by revenue
SLQT
SLQT
1.2× larger
SLQT
$537.1M
$461.5M
CCO
Growing faster (revenue YoY)
SLQT
SLQT
+3.5% gap
SLQT
11.6%
8.2%
CCO
Higher net margin
SLQT
SLQT
11.2% more per $
SLQT
12.9%
1.7%
CCO
More free cash flow
CCO
CCO
$31.4M more FCF
CCO
$30.3M
$-1.0M
SLQT
Faster 2-yr revenue CAGR
SLQT
SLQT
Annualised
SLQT
19.5%
18.8%
CCO

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CCO
CCO
SLQT
SLQT
Revenue
$461.5M
$537.1M
Net Profit
$8.0M
$69.3M
Gross Margin
61.8%
Operating Margin
23.3%
14.0%
Net Margin
1.7%
12.9%
Revenue YoY
8.2%
11.6%
Net Profit YoY
144.8%
30.2%
EPS (diluted)
$0.01
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCO
CCO
SLQT
SLQT
Q4 25
$461.5M
$537.1M
Q3 25
$405.6M
$328.8M
Q2 25
$402.8M
$345.1M
Q1 25
$334.2M
$408.2M
Q4 24
$426.7M
$481.1M
Q3 24
$375.2M
$292.3M
Q2 24
$376.5M
$307.2M
Q1 24
$326.8M
$376.4M
Net Profit
CCO
CCO
SLQT
SLQT
Q4 25
$8.0M
$69.3M
Q3 25
$-60.1M
$-30.5M
Q2 25
$9.5M
$12.9M
Q1 25
$62.5M
$26.0M
Q4 24
$-17.9M
$53.2M
Q3 24
$-32.5M
$-44.5M
Q2 24
$-39.2M
$-31.0M
Q1 24
$-89.7M
$8.6M
Gross Margin
CCO
CCO
SLQT
SLQT
Q4 25
61.8%
Q3 25
41.4%
Q2 25
47.2%
Q1 25
60.2%
Q4 24
67.5%
Q3 24
55.7%
Q2 24
60.7%
Q1 24
71.8%
Operating Margin
CCO
CCO
SLQT
SLQT
Q4 25
23.3%
14.0%
Q3 25
19.9%
-12.4%
Q2 25
19.2%
-3.6%
Q1 25
13.5%
5.4%
Q4 24
23.5%
14.7%
Q3 24
17.8%
-4.1%
Q2 24
18.2%
-0.5%
Q1 24
13.4%
8.8%
Net Margin
CCO
CCO
SLQT
SLQT
Q4 25
1.7%
12.9%
Q3 25
-14.8%
-9.3%
Q2 25
2.4%
3.7%
Q1 25
18.7%
6.4%
Q4 24
-4.2%
11.1%
Q3 24
-8.7%
-15.2%
Q2 24
-10.4%
-10.1%
Q1 24
-27.4%
2.3%
EPS (diluted)
CCO
CCO
SLQT
SLQT
Q4 25
$0.01
$0.26
Q3 25
$-0.12
$-0.26
Q2 25
$0.02
$-0.06
Q1 25
$0.13
$0.03
Q4 24
$-0.03
$0.30
Q3 24
$-0.07
$-0.26
Q2 24
$-0.08
$-0.17
Q1 24
$-0.19
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCO
CCO
SLQT
SLQT
Cash + ST InvestmentsLiquidity on hand
$190.0M
$18.3M
Total DebtLower is stronger
$5.1B
$405.8M
Stockholders' EquityBook value
$-3.4B
$359.7M
Total Assets
$3.8B
$1.4B
Debt / EquityLower = less leverage
1.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCO
CCO
SLQT
SLQT
Q4 25
$190.0M
$18.3M
Q3 25
$155.0M
$10.7M
Q2 25
$138.6M
$32.4M
Q1 25
$395.8M
$80.1M
Q4 24
$109.7M
$7.3M
Q3 24
$201.1M
$10.4M
Q2 24
$189.3M
$42.7M
Q1 24
$193.2M
$37.8M
Total Debt
CCO
CCO
SLQT
SLQT
Q4 25
$5.1B
$405.8M
Q3 25
$5.1B
$393.1M
Q2 25
$5.1B
$385.1M
Q1 25
$5.3B
$391.5M
Q4 24
$5.7B
$711.9M
Q3 24
$5.7B
$680.4M
Q2 24
$5.7B
$683.3M
Q1 24
$5.7B
$686.0M
Stockholders' Equity
CCO
CCO
SLQT
SLQT
Q4 25
$-3.4B
$359.7M
Q3 25
$-3.5B
$305.1M
Q2 25
$-3.4B
$351.1M
Q1 25
$-3.4B
$350.2M
Q4 24
$-3.6B
$326.0M
Q3 24
$-3.6B
$269.4M
Q2 24
$-3.6B
$316.8M
Q1 24
$-3.5B
$346.8M
Total Assets
CCO
CCO
SLQT
SLQT
Q4 25
$3.8B
$1.4B
Q3 25
$3.8B
$1.2B
Q2 25
$3.8B
$1.2B
Q1 25
$4.0B
$1.3B
Q4 24
$4.8B
$1.3B
Q3 24
$4.6B
$1.1B
Q2 24
$4.5B
$1.2B
Q1 24
$4.6B
$1.2B
Debt / Equity
CCO
CCO
SLQT
SLQT
Q4 25
1.13×
Q3 25
1.29×
Q2 25
1.10×
Q1 25
1.12×
Q4 24
2.18×
Q3 24
2.53×
Q2 24
2.16×
Q1 24
1.98×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCO
CCO
SLQT
SLQT
Operating Cash FlowLast quarter
$56.3M
$52.0K
Free Cash FlowOCF − Capex
$30.3M
$-1.0M
FCF MarginFCF / Revenue
6.6%
-0.2%
Capex IntensityCapex / Revenue
5.6%
0.2%
Cash ConversionOCF / Net Profit
7.04×
0.00×
TTM Free Cash FlowTrailing 4 quarters
$32.0M
$8.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCO
CCO
SLQT
SLQT
Q4 25
$56.3M
$52.0K
Q3 25
$56.2M
$-21.6M
Q2 25
$-12.6M
$-37.5M
Q1 25
$14.9M
$71.1M
Q4 24
$29.3M
$-28.7M
Q3 24
$54.5M
$-16.6M
Q2 24
$30.8M
$20.0M
Q1 24
$-34.8M
$44.5M
Free Cash Flow
CCO
CCO
SLQT
SLQT
Q4 25
$30.3M
$-1.0M
Q3 25
$41.4M
$-22.7M
Q2 25
$-29.2M
$-38.0M
Q1 25
$-10.6M
$70.2M
Q4 24
$-27.8M
$-29.0M
Q3 24
$21.0M
$-17.1M
Q2 24
$5.2M
$19.7M
Q1 24
$-61.0M
$43.4M
FCF Margin
CCO
CCO
SLQT
SLQT
Q4 25
6.6%
-0.2%
Q3 25
10.2%
-6.9%
Q2 25
-7.2%
-11.0%
Q1 25
-3.2%
17.2%
Q4 24
-6.5%
-6.0%
Q3 24
5.6%
-5.8%
Q2 24
1.4%
6.4%
Q1 24
-18.7%
11.5%
Capex Intensity
CCO
CCO
SLQT
SLQT
Q4 25
5.6%
0.2%
Q3 25
3.7%
0.3%
Q2 25
4.1%
0.1%
Q1 25
7.6%
0.2%
Q4 24
13.4%
0.1%
Q3 24
8.9%
0.2%
Q2 24
6.8%
0.1%
Q1 24
8.0%
0.3%
Cash Conversion
CCO
CCO
SLQT
SLQT
Q4 25
7.04×
0.00×
Q3 25
Q2 25
-1.32×
-2.91×
Q1 25
0.24×
2.73×
Q4 24
-0.54×
Q3 24
Q2 24
Q1 24
5.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCO
CCO

Segment breakdown not available.

SLQT
SLQT

Healthcare Services Segment$230.7M43%
Pharmacy$227.2M42%
Other$30.4M6%
Final Expense$20.4M4%
Term$18.5M3%
Other Senior$6.3M1%
All Other Revenue$3.9M1%

Related Comparisons